Under construction – not a live service
Sign in
Not yet recruitingNo phase

A Multi-Center Study on the Clinical Advantages of Personalized Total Knee Arthroplasty System

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 80 years old?

Source: NCT07003035, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
YujiakuoTHU
Trial code
NCT07003035
Record updated
4 June 2025
Original description
The purpose of this study is to evaluate the clinical benefits of personalized total knee arthroplasty (TKA) in comparison with conventional TKA. The study aims to assess surgical outcomes, functional recovery, complication rates, and cost-effectiveness in a multi-center, prospective cohort study.Read full original descriptionShow less

A Multi-Center Prospective Cohort Study on the Clinical Advantages of Personalized Total Knee Arthroplasty System

The purpose of this study is to evaluate the clinical benefits of personalized total knee arthroplasty (TKA) in comparison with conventional TKA. The study aims to assess surgical outcomes, functional recovery, complication rates, and cost-effectiveness in a multi-center, prospective cohort study.

Inclusion: Patients aged 50-80 years; Diagnosed with end-stage knee osteoarthritis, post-traumatic arthritis, avascular necrosis, or inflammatory arthritis requiring total knee arthroplasty; Willing and able to provide informed consent.

Exclusion: History of prior knee surgery or knee replacement; Undergoing total knee revision surgery; Neuromuscular disorders affecting knee stability or gait; Presence of significant comorbidities posing unacceptable risk, including but not limited to metabolic, renal, hepatic, pulmonary, cardiac, hematologic, neurological, endocrine, infectious, or gastrointestinal conditions; Active or recent severe infections or malignancy; History of drug or alcohol abuse in the past six months; Severe knee deformity (valgus >20° or varus >15°) or instability; Severe contracture (>25° flexion contracture); Rheumatoid arthritis diagnosis; BMI >35; Pregnancy or lactation.

ClinicalTrials.gov NCT07003035